5 Top IPOs to Watch in July 2015
Investors may want to keep an eye on the following initial public offerings (IPOs) in July 2015 as they offer a unique opportunity to get involved in a publicly-traded company on the first day of trading.
IPOs this month are coming from a variety of industries; from finance, to pharmaceutical to information technology.
Below is a preview of the five biggest offerings this week. Keep in mind that many investors with visions of quick money to be made may underestimate potential risks and jump in at any cost.
Chiasma Inc. (NASDAQ/CHMA)
Chiasma Inc. (NASDAQ/CHMA) submitted a filing to the Securities and Exchange Commission (SEC) on Jun 15, 2015 about its IPO. The company has applied to list on NASDAQ under the symbol “CHMA.” Chiasma is expected to offer over five million shares between $13.00 and $15.00 per share through main underwriters Barclays, Cowen & Company, and William Blair.
The company, which was founded in 2001, operates in the Biopharmaceutical industry. The company improves the lives of patients by transforming injectable drugs into oral medications.
Ollie’s Bargain Outlet Holdings (NASDAQ/OLLI)
Ollie’s Bargain Outlet Holdings (NASDAQ/OLLI) is expected to hit the market next week. The company submitted a filing to the SEC on June 15, 2015 about its IPO. The company has applied to list on the NASDAQ under the symbol “OLLI” with about nine million shares between the price of $13.00 and $15.00 per share, through main underwriters J.P. Morgan, Jefferies, and BofA Merrill Lynch.
Ollie’s Bargain Outlet is one of America’s largest retailers of closeouts, excess inventory, and salvage merchandise. The company offers hardware, books and stationery, carpet, domestics, food, toys, and seasonal goods.
Also Read: Top Five Upcoming IPOs to Watch For 2015
ProNAi Therapeutics (NASDAQ/DNAI)
ProNAi Therapeutics (NASDAQ/DNAI) submitted a filling to the SEC to go public on June 12, 2015. The company has applied to list on NASDAQ under the symbol “DNAI.” The company is expected to offer about seven million shares between $14.00 and $16.00 per share through the main underwriters Jefferies, BofA Merrill Lynch, and Wedbush PacGrow.
ProNai is a clinical-stage oncology company pioneering a novel class of therapeutics based on a proprietary DNA interference technology platform. The company’s vision is to be the leader in developing and commercializing a portfolio of DNA-based therapies to deliver extraordinary therapeutic outcomes that dramatically change patients’ lives.
Jupai Holdings (NYSE/JP)
Jupai Holdings (NYSE/JP) submitted a filing to the SEC on June 15, 2015 about its IPO. The company has applied to list on NYSE under the symbol “JP.” Jupai is expected to offer about six million shares between $10.00 and $12.00 per share through the main underwriters Credit Suisse and China Renaissance.
Jupai was founded in 2010. The firm provides asset management products, mutual funds, and investment banking services to wealthy individual investors in China.
Rapid7 (NASDAQ/RPD)
Rapid7 (NASDAQ/RPD) submitted a filing to the SEC on June 11, 2015 about its IPO. The company has applied to list on NASDAQ under the symbol “PRD” and is expected to offer over nine million shares between $13.00 and $15.00 per share through main underwriters Morgan Stanly, Barclays, and Pacific Crest.
Rapid7 was founded in 2000 and provides enterprise network security software. The Boston-based cyber security firm uses data analytics to reduce security threats and detect system intrusions.
